WhiteOak Capital Pharma and Healthcare Fund - Direct - Growth

Equity Scheme by WhiteOak Capital Asset Management Limited

1Y Returns (CAGR)
17.01%
Expense Ratio
1.20%

as of 01/07/2026

AUM
₹132.63 Cr

Qtr End: Jun 26

NAV
₹16.801

as of 17/07/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M16.75%85.77%12.54%
6M20.60%45.45%14.90%
1Y17.01%17.01%13.31%
3YN/AN/AN/A
5YN/AN/AN/A
Scheme Details
Launch Date
16/01/2024
Fund Age
2.5 years
Minimum Investment
₹500
Fund House
WhiteOak Capital Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions